SCYNEXIS and Aspire Capital Enter into $20 Million Common Stock Purchase Agreement – BioSpaceBy / April 13, 2020 SCYNEXIS and Aspire Capital Enter into $20 Million Common Stock Purchase Agreement BioSpace Share this:TweetReddit
